Pisa syndrome during aripiprazole treatment: A case report

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 1, 2007, Pages 286-287

  Rota, Eugenia ^a   Bergesio, Giovanni ^a   Dettoni, Elisabetta ^a   Demicheli, Claudio M ^a  

^a Clinical Neurology   (Italy)

Author keywords

Aripiprazole; Atypical antipsychotics; Dystonia; Extrapyramidal side effects; Pisa syndrome

Indexed keywords

ACETYLSALICYLIC ACID; ARIPIPRAZOLE; BENZODIAZEPINE; CLONAZEPAM; QUETIAPINE;

AGED; ARTICLE; BEHAVIOR; BODY MOVEMENT; CASE REPORT; DEMENTIA; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GERIATRIC PATIENT; HUMAN; PISA SYNDROME; PSYCHOSIS; SYMPTOM; SYNDROME DELINEATION; TREATMENT OUTCOME;

AGED; ANTIPSYCHOTIC AGENTS; DEMENTIA; DIBENZOTHIAZEPINES; DYSTONIA; FEMALE; HUMANS; PIPERAZINES; QUINOLONES;

EID: 33845753338     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.06.009     Document Type: Article

References (12)

1. Coffey G.L., Botts S.R., and de Leon J. High vulnerability to acute dystonic reactions: a case of antipsychotic exposure and uncontrolled seizure activity. Prog Neuropharmacol Biol Psychiatry 29 5 (2005) 770-774
2. Colosimo C. Pisa syndrome in a patient with multiple system atrophy. Mov Disord 13 (1998) 607-609
3. Duggal H.S., Sivamony S., and Umapathy C. Pisa syndrome and atypical antipsychotics [letter]. Am J Psychiatry 161 2 (2004) 373
4. Fernandez H.H., Trieschmann M.E., and Friedman J.H. Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experience. Clin Neuropharmacol 27 1 (2004) 4-5
5. Goodnick P.J., and Jerry J.M. Aripiprazole: profile on efficacy and safety. Expert Opin Pharmacother 3 (2002) 1773-1781
6. Patel S., Tariot P.N., and Hamill R.W. Pisa syndrome without neuroleptic exposure in a patient with dementia of the Alzheimer type. J Geriatr Psychiatry Neurol 4 (1991) 48-51
7. Sharma A., and Sorrell J.H. Aripiprazole-induced parkinsonism. Int Clin Psychopharmacol 21 2 (2006) 127-129
8. Stubner S., Padberg F., Grohmann R., Hampel H., Hollweg M., Hippius H., et al. Pisa syndrome (pleurothotonus): report of a multicenter drug safety surveillance project. J Clin Psychiatry 61 (2000) 569-574
9. Suzuki T., and Matsuzaka H. Drug-induced Pisa syndrome (pleurothotonus). Epidemiology and management. CNS Drugs 16 3 (2002) 165-174
10. Villarejo A., Camacho A., Garcia-Ramos R., Moreno T., Penas M., Juntas R., et al. Cholinergic-dopaminergic imbalance in Pisa syndrome. Clin Neuropharmacol 26 (2003) 119-121
11. Wetterling T., Kanitz R.D., and Borgis K.J. The ICD-10 criteria for vascular dementia. Dementia 5 3-4 (1994) 185-188
12. 11C]raclopride. Neuropsychopharmacol 27 (2002) 248-259